Potential Prophylactic Treatments for COVID-19
The World Health Organization declared the SARS-CoV-2 outbreak a Public Health Emergency of International Concern at the end of January 2020 and a pandemic two months later. The virus primarily spreads between humans via respiratory droplets, and is the causative agent of Coronavirus Disease 2019 (C...
Main Authors: | Noam Ben-Zuk, Ido-David Dechtman, Itai Henn, Libby Weiss, Amichay Afriat, Esther Krasner, Yoav Gal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/13/7/1292 |
Similar Items
-
Systematic review of registered trials of Hydroxychloroquine prophylaxis for COVID-19 health-care workers at the first third of 2020
by: Anne-Lise Bienvenu, et al.
Published: (2020-12-01) -
Knowledge of PEP and PrEP among people living with HIV/aids in Brazil
by: Laelson Rochelle Milanês Sousa, et al.
Published: (2021-01-01) -
Pre-Exposure Prophylaxis for COVID-19 in Pregnant Women
by: Fesler MC, et al.
Published: (2021-01-01) -
Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis
by: Raphael B. Stricker, et al.
Published: (2021-09-01) -
Purified Vero Cell Rabies Vaccine (PVRV, Verorab<sup>®</sup>): A Systematic Review of Intradermal Use Between 1985 and 2019
by: Thomas Moulenat, et al.
Published: (2020-03-01)